# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Jim Cramer, the host of CNBC's "Mad Money," has warned investors about the current state of the economy and suggest...
- CX-801 is a dually masked, conditionally activated IFNα2b cytokine designed using the CytomX Probody® Therapeutic Platform
-SEC Filing
Unlocking global access to Bacillus Calmette-Guerin (BCG) for cancer therapy. ImmunityBio partners with Serum Institute to expa...
U.S. labor market misses April expectations, signaling slower economic growth and potential interest rate cuts. Stocks rise, Tr...